McKesson Ventures Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 8

Professionals
  • Investments
  • 63

  • Portfolio
  • 29

  • Exits
  • 17

Exits

McKesson Ventures General Information

Description

Founded in 2014, McKesson Ventures is the corporate venture capital arm of McKesson and is based in San Francisco, California. The firm seeks to invest in companies within the healthcare industry with a specific focus on digital health and technology-enabled services serving the needs of pharma, pharmacy, providers, and patients.

Contact Information

Year Founded
2014
Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Primary Investor Type
Corporate Venture Capital
Primary Office
  • One Post Street
  • 21st Floor
  • San Francisco, CA 94104
  • United States

McKesson Ventures Investments (63)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
CancerIQ 03-Mar-2022 Later Stage VC 0000 Decision/Risk Analysis Generating Revenue
0000000 000000 07-Feb-2022 00000 00000 0000 Other Healthcare Technology Systems Generating Revenue
000000000 0000 30-Jan-2022 00000 00000 0000 Clinics/Outpatient Services Generating Revenue
000000000 19-Jan-2022 00 000000000 Enterprise Systems (Healthcare) Generating Revenue
00000 000000000 17-Nov-2021 00000 00000 00000 Decision/Risk Analysis Generating Revenue 00000 0000000
0000000 000000000 08-Nov-2021 0000000000 Other Healthcare Technology Systems Generating Revenue 00000 0000000
000000000 (0000000 24-Sep-2021 00000 00000 0000 Enterprise Systems (Healthcare) Generating Revenue 00000 0000000
0000.00 21-Sep-2021 00000 00000 0000 Business/Productivity Software Generating Revenue 000000 00000000
AllStripes 24-Aug-2021 Early Stage VC 0000 Medical Records Systems Generating Revenue
Lifted 08-Jun-2021 Early Stage VC 00.000 Elder and Disabled Care Generating Revenue 000 0000000
You’re viewing 10 of 63 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

McKesson Ventures Exits (17)

Company Name Exit Date Exit Type Exit Size
Augmedix 28-Oct-2021 Public Investment 2nd Offering 0000
00000 18-Aug-2021 000000000000000000 00.00
0000 & 0000 000000 19-Jan-2021 0000000 000000 00000
000000 17-Sep-2020 000 00000
0000000000 18-Aug-2020 000000000000000000
00000000 02-Jul-2020 000 00000
00000000 15-Jun-2020 000000000000000000 00000
00000000 07-Jan-2020 0000000000
Unforgettable 12-Jun-2019 Merger/Acquisition
Propeller Health 06-Jan-2019 Merger/Acquisition 00000
You’re viewing 10 of 17 exits. Get the full list »

McKesson Ventures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

McKesson Ventures Team (15)

Name Title Deals Funds Boards Office
David Schulte Senior Vice President & Managing Director 00 0 0 San Francisco, CA
Carrie Williams Partner 0 0 San Francisco, CA
Michelle Snyder Partner 0 San Francisco, CA
Ashley Ng Director San Francisco, CA
Lizzie Lee Senior Director & Head of Portfolio Development and Market Research San Francisco, CA
You’re viewing 5 of 15 team members. Get the full list »

McKesson Ventures Co-Investors (158)

Name With Exits Lead Partner Series Industry
dRx Capital 5 0 Series chart Industry bar
Merck Global Health Innovation Fund 0 0 Series chart Industry bar
Lux Capital 0 0 Series chart Industry bar
Marc Benioff 0 0 0 Series chart Industry bar
Novartis Pharma 0 0 Series chart Industry bar
You’re viewing 5 of 158 co-investors. Get the full list »